Janku Filip (CIK 1862930) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Sell GLUE (5,407 shares), Buy GLUE (5,407 shares), Buy GLUE (6,000 shares), Sell GLUE (6,000 shares), Buy GLUE (6,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Sell | 5,407 | $132,472 |
| 2026-07-01 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Buy | 5,407 | $72,508 |
| 2026-06-30 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Buy | 6,000 | $45,360 |
| 2026-06-30 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Sell | 6,000 | $137,700 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Buy | 6,000 | $45,360 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Sell | 11,845 | $239,522 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Buy | 30,000 | $226,800 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Sell | 30,000 | $642,681 |
| 2026-02-24 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Sell | 9,189 | $179,186 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Buy | 31,000 | $0 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Medical Officer | Sell | 3,155 | $47,861 |
Source: SEC Form 4 filings · as of 2026-07-01